GSK Consumer Sales Remain Strong As Rx Revenue Slips
This article was originally published in The Tan Sheet
Executive Summary
Sales of GlaxoSmithKline's OTC and other consumer health care products far outpaced its prescription drugs, which brought overall sales down 3 percent in the firm's fiscal 2008 first quarter